Jury Awards $40 Million to Two Women in Landmark Johnson & Johnson Talc Trial

Spread the Message

Read Time:4 Minute, 22 Second

December 14, 2025

LOS ANGELES — In a significant legal defeat for Johnson & Johnson (J&J) following its failed attempts to resolve mass litigation through bankruptcy courts, a Los Angeles Superior Court jury has ordered the healthcare giant to pay $40 million to two women who alleged the company’s talc-based baby powder caused their ovarian cancer.

The verdict, delivered late Friday, marks the first trial conclusion since a federal judge dismissed J&J’s third bankruptcy filing in April 2025—a legal maneuver that had previously frozen tens of thousands of similar lawsuits. The jury found that Johnson & Johnson was aware for decades that its talc products could contain asbestos, a known carcinogen, yet failed to warn consumers of the potential risks.

The Verdict: A Detailed Breakdown

The jury awarded a total of $40 million in compensatory damages to the plaintiffs, both long-term users of the company’s iconic baby powder.

Monica Kent, diagnosed with ovarian cancer in 2014, was awarded $18 million.
Deborah Schultz (along with her husband, Dr. Albert Schultz), diagnosed in 2018, was awarded $22 million.

Both women testified that they had used J&J’s talc-based products daily for nearly 40 to 50 years, trusting the brand’s reputation for safety. Their attorneys argued that this loyalty was met with betrayal, presenting internal company documents suggesting executives were concerned about asbestos contamination as far back as the 1970s but chose not to disclose these concerns to regulators or the public.

Key testimony came from Dr. David Kessler, a former Commissioner of the U.S. Food and Drug Administration (FDA). Kessler testified that J&J’s alleged concealment of asbestos evidence spanned more than five decades, stating the company “manipulated scientific research and misled regulators.”

Johnson & Johnson’s Response

Johnson & Johnson has vowed to appeal the decision immediately. Erik Haas, J&J’s Worldwide Vice President of Litigation, described the verdict as “irreconcilable with the decades of independent scientific evaluations confirming that talc is safe, does not contain asbestos, and does not cause cancer.”

The company maintains that it has won the majority of cases that have gone to trial and attributes adverse verdicts to “aberrant” jury findings rather than scientific fact. J&J ceased sales of talc-based baby powder in North America in 2020 and discontinued the product globally in 2023, replacing the main ingredient with cornstarch.

The Science: Talc, Asbestos, and Ovarian Cancer

The trial highlights a contentious medical debate regarding the link between perineal (genital) talc use and ovarian cancer. Talc is a naturally occurring mineral often mined near asbestos, creating a risk of cross-contamination if not strictly purified.

“The primary concern with talc has always been twofold,” explains Dr. Elena Rodriguez, a gynecologic oncologist not involved in the litigation. “First, there is the risk of asbestos contamination, which is universally accepted as carcinogenic. Second, there is the theory that talc particles themselves can migrate through the reproductive tract to the ovaries, causing chronic inflammation that may lead to cellular mutation.”

While the International Agency for Research on Cancer (IARC), part of the World Health Organization, reclassified talc as “probably carcinogenic to humans” in a 2024 review, the epidemiological evidence remains mixed:

Statistical Association: Several case-control studies have shown a modest increase in ovarian cancer risk (approximately 30%) among frequent users.
Causation Debate: Large prospective cohort studies have historically struggled to prove a definitive causal link, though recent pooled analyses have suggested a stronger association than previously thought.

“For the general public, the absolute risk remains relatively low,” Dr. Rodriguez notes. “However, given that ovarian cancer is difficult to detect early and has high mortality rates, any avoidable risk factor is significant from a public health perspective.”

Legal and Public Health Implications

This verdict serves as a bellwether for the roughly 67,000 pending lawsuits against J&J. The failure of the “Texas Two-Step” bankruptcy strategy—which attempted to offload talc liabilities into a subsidiary that would then declare insolvency—means these cases can now proceed to trial in state courts.

For consumers, this case underscores the importance of ingredient awareness.

Check Labels: While J&J has switched to cornstarch, other cosmetic products (like eyeshadows and face powders) may still contain talc.
Cornstarch Alternatives: Cornstarch-based powders have not been linked to ovarian cancer and are considered a safe alternative for moisture control.

“This verdict sends a message that corporate transparency is non-negotiable when it comes to consumer health,” said Andy Birchfield, lead trial counsel for the plaintiffs. “These women suffered because information was withheld.”

As the appeals process begins, the legal battle over the safety of one of America’s most famous consumer products is far from over.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.